Patient outcomes from lung cancer and diabetes mellitus: a matched case–control study | Zendy

Nina J. Karlin | Zendy; Shailja B Amin | Zendy; Matthew Buras | Zendy; Heidi E. Kosiorek | Zendy; Patricia M Verona | Zendy; Curtiss B. Cook | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Patient outcomes from lung cancer and diabetes mellitus: a matched case–control study

Author(s) -

Nina J. Karlin,

Shailja B Amin,

Matthew Buras,

Heidi E. Kosiorek,

Patricia M Verona,

Curtiss B. Cook

Publication year - 2017

Publication title -

future science oa

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.825

H-Index - 23

ISSN - 2056-5623

DOI - 10.4155/fsoa-2017-0081

Subject(s) - diabetes mellitus , medicine , lung cancer , oncology , cancer , case control study , lung , bioinformatics , intensive care medicine , endocrinology , biology

Aim: This case–control study examined the impact of diabetes mellitus (DM) on survival in lung cancer patients and lung cancer on glycemic control in DM. Materials & methods: Patients with a new lung cancer diagnosis and DM (n = 124) were matched to 124 lung cancer patients without DM. Laboratory results and DM and cancer therapies were obtained from electronic records. Results: Five-year overall survival for lung cancer patients with and without DM was 20 versus 29% (p = .12). Glycemic control among DM patients did not change significantly with time. Conclusion: DM does not cause adverse impact on lung cancer survival. Lung cancer does not affect glycemic control.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research